Arrowstreet Capital Limited Partnership grew its position in TriMas Co. (NASDAQ:TRS – Free Report) by 38.5% in the fourth quarter, Holdings Channel.com reports. The fund owned 255,560 shares of the industrial products company’s stock after buying an additional 71,088 shares during the period. Arrowstreet Capital Limited Partnership’s holdings in TriMas were worth $6,284,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds have also made changes to their positions in the company. FMR LLC increased its stake in TriMas by 1.7% during the third quarter. FMR LLC now owns 44,082 shares of the industrial products company’s stock valued at $1,125,000 after purchasing an additional 729 shares during the last quarter. State Street Corp raised its stake in TriMas by 4.1% during the third quarter. State Street Corp now owns 994,114 shares of the industrial products company’s stock worth $25,380,000 after acquiring an additional 39,497 shares during the period. Wellington Management Group LLP raised its stake in TriMas by 10.7% during the third quarter. Wellington Management Group LLP now owns 2,619,359 shares of the industrial products company’s stock worth $66,872,000 after acquiring an additional 252,537 shares during the period. Jane Street Group LLC raised its stake in TriMas by 74.4% during the third quarter. Jane Street Group LLC now owns 82,621 shares of the industrial products company’s stock worth $2,109,000 after acquiring an additional 35,258 shares during the period. Finally, XTX Topco Ltd bought a new position in TriMas in the third quarter worth about $371,000. 99.42% of the stock is owned by institutional investors and hedge funds.
TriMas Stock Performance
Shares of TRS opened at $20.46 on Tuesday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.44 and a current ratio of 2.83. TriMas Co. has a 1 year low of $19.33 and a 1 year high of $28.51. The firm has a fifty day moving average of $23.46 and a 200-day moving average of $24.88. The company has a market cap of $833.05 million, a price-to-earnings ratio of 31.97 and a beta of 0.55.
TriMas Announces Dividend
Analyst Ratings Changes
Separately, BWS Financial reiterated a “buy” rating and set a $40.00 price target on shares of TriMas in a research report on Friday, February 28th.
Check Out Our Latest Research Report on TRS
Insider Activity
In related news, Director Jeffrey A. Fielkow purchased 2,500 shares of the company’s stock in a transaction on Friday, February 28th. The shares were bought at an average cost of $20.78 per share, for a total transaction of $51,950.00. Following the transaction, the director now owns 11,013 shares of the company’s stock, valued at $228,850.14. This represents a 29.37 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link. Also, Director Shawn Sedaghat acquired 249,597 shares of the firm’s stock in a transaction dated Friday, March 7th. The stock was bought at an average price of $23.83 per share, with a total value of $5,947,896.51. Following the completion of the acquisition, the director now directly owns 346,825 shares of the company’s stock, valued at approximately $8,264,839.75. This represents a 256.71 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders have acquired 806,246 shares of company stock valued at $19,338,213. Insiders own 1.10% of the company’s stock.
TriMas Profile
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Recommended Stories
- Five stocks we like better than TriMas
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Options Activity Points to More Volatility for Palantir Stock
- What Are Earnings Reports?
- NVIDIA Stock: Oversold, Undervalued — How Low Can It Go?
- Business Services Stocks Investing
- MicroStrategy Sees Insider Buy-Sell Action in Q1
Want to see what other hedge funds are holding TRS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TriMas Co. (NASDAQ:TRS – Free Report).
Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.